Jay S Skyler


  • 12889 Citations
1968 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Jay S Skyler is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


  • Type 1 Diabetes TrialNet

    Skyler, J. S.

    National Institutes of Health


    Project: Research project


    Skyler, J. S., Ironson, G., Kumar, M., Saab, P., Llabre, M., Schneiderman, N., Hurwitz, B., Goldberg, R. B., Nagel, J., Gerace, T., Schnederman, N., Mc Cabe, P., McCabe, P. & Skylar, J.

    National Institutes of Health


    Project: Research project

  • Research Output

    A Wake-Up Call

    Skyler, J. S., Feb 2020, In : Diabetes Technology and Therapeutics. 22, 2, 1 p.

    Research output: Contribution to journalComment/debate


    Skyler, J. S., Jan 1 2020, Behavioral Diabetes: Social Ecological Perspectives for Pediatric and Adult Populations. Springer International Publishing, p. ix

    Research output: Chapter in Book/Report/Conference proceedingForeword/postscript

    Low-dose empagliflozin as adjunct-to-insulin therapy in type 1 diabetes: A valid modelling and simulation analysis to confirm efficacy

    Perkins, B. A., Soleymanlou, N., Rosenstock, J., Skyler, J. S., Laffel, L. M., Liesenfeld, K. H., Neubacher, D., Riggs, M. M., Johnston, C. K., Eudy-Byrne, R. J., Elmokadem, A., George, J. T., Marquard, J. & Nock, V., Mar 1 2020, In : Diabetes, Obesity and Metabolism. 22, 3, p. 427-433 7 p.

    Research output: Contribution to journalArticle

    Open Access
  • Practical recommendations for the management of diabetes in patients with COVID-19

    Bornstein, S. R., Rubino, F., Khunti, K., Mingrone, G., Hopkins, D., Birkenfeld, A. L., Boehm, B., Amiel, S., Holt, R. IG., Skyler, J. S., DeVries, J. H., Renard, E., Eckel, R. H., Zimmet, P., Alberti, K. G., Vidal, J., Geloneze, B., Chan, J. C., Ji, L. & Ludwig, B., Jan 1 2020, (Accepted/In press) In : The Lancet Diabetes and Endocrinology.

    Research output: Contribution to journalReview article

    Open Access
  • 17 Scopus citations

    An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes

    Herold, K. C., Bundy, B. N., Alice Long, S., Bluestone, J. A., DiMeglio, L. A., Dufort, M. J., Gitelman, S. E., Gottlieb, P. A., Krischer, J. P., Linsley, P. S., Marks, J. B., Moore, W., Moran, A., Rodriguez, H., Russell, W. E., Schatz, D., Skyler, J. S., Tsalikian, E., Wherrett, D. K., Ziegler, A. G. & 1 others, Greenbaum, C. J., Aug 15 2019, In : New England Journal of Medicine. 381, 7, p. 603-613 11 p.

    Research output: Contribution to journalArticle

  • 58 Scopus citations